ArticleBMC complementary medicine and therapies2026
Effects of a brown rice-derived supplement on physical, cognitive and mental health among adults and the role of the gut microbiota: study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe consumption of brown rice, which contains bran and germ and is rich in fiber, micronutrients, and phytochemicals, can contribute to good physical, cognitive, and mental health. However, these health benefits and the relevant mechanisms have not been fully elucidated, especially in human subjects. Therefore, we will conduct a randomized controlled trial to examine the effects of a brown rice-derived supplement on various aspects of health and to elucidate the underlying mechanisms.
methodsThis study will be a prospective, longitudinal, double-blind, randomized, placebo-controlled trial. Eighty healthy adults aged 20 to 64 years will receive 3.5 g/day of a brown rice-derived supplement or placebo for 12 weeks. We will assess immune-related and metabolic markers using transcriptome and metabolome analyses of blood samples, respectively, and evaluate the gut microbiota composition using stool samples, including 16S rRNA-based analysis, with short-chain fatty acids also measured. Cognitive function, constipation, sleep, mood state, and health-related quality of life will also be assessed using validated assessments at baseline and at the endpoint. Between-group comparisons will be conducted using appropriate statistical methods according to the distribution and characteristics of the data. DISCUSSION: This study is the first to examine the effects of a brown rice-derived supplement on various aspects of health, including immune, cognitive, physical and mental health. We hypothesize that changes in the variation in the gut microbiota play a key role in the mechanisms underlying these health effects; therefore, we will investigate how changes in the gut microbiota caused by the consumption of the brown rice-derived supplement affect health status. We hope that the information derived from this study will be useful for promoting the use of brown rice-derived supplements as a healthy food and improving public health.
trial registrationUniversity Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR), UMIN000049330. Registered on 8 November 2022. https://rctportal.niph.go.jp/en/detail?trial_id=UMIN000049330
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.